logo

CRDL

Cardiol Therapeutics·NASDAQ
--
--(--)
--
--(--)

CRDL fundamentals

Cardiol Therapeutics (CRDL) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.0862 (YoY +35.19%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.0862
+35.19%
Report date
Nov 13, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Cardiol Therapeutics (CRDL) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Cardiol Therapeutics (CRDL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Cardiol Therapeutics (CRDL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Cardiol Therapeutics (CRDL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Cardiol Therapeutics (CRDL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Cardiol Therapeutics (CRDL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield